Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.
- DOI
- 10.1002/jgm.3576
- Published
- 2024 Jan
- Container
- The journal of gene medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jgm.3576,
title = {Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.},
author = {Sallard E and Schulte L and van den Boom A and Klimovitskii A and Knierer J and Hagedorn C and Knocks M and Zhang W and Kreppel F and Ehrhardt A and Ehrke-Schulz E},
year = {2024},
journal = {The journal of gene medicine},
doi = {10.1002/jgm.3576},
url = {https://doi.org/10.1002/jgm.3576}
}RIS
TY - JOUR TI - Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5. AU - Sallard E AU - Schulte L AU - van den Boom A AU - Klimovitskii A AU - Knierer J AU - Hagedorn C AU - Knocks M AU - Zhang W AU - Kreppel F AU - Ehrhardt A AU - Ehrke-Schulz E PY - 2024 JO - The journal of gene medicine DO - 10.1002/jgm.3576 UR - https://doi.org/10.1002/jgm.3576 ER -
APA
E, S., L, S., A, V. D. B., A, K., J, K., C, H., M, K., W, Z., F, K., A, E., & E, E. (2024). Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5.. The journal of gene medicine. https://doi.org/10.1002/jgm.3576
Source records
- pubmed · retrieved 2026-09-27T12:37:24.929Z